Vista Exclusive Content
J&J Continuing Research For Mid-Stage HIV Vaccine
As per reports, Johnson & Johnson (JNJ) is staged to move forward with a late-stage study of an investigational vaccine for Human Immunodeficiency Virus (HIV), a condition that weakens the immune system of the body in countries like America and Europe. The company is continuing its
Israeli’s Nutritional Insights Provider DayTwo Raises $31 Million Funding via Seventure Partners & Johnson & Johnson
Reportedly, Israel’s DayTwo raised $31 million in private financing bringing in a total of $48 million funding for the health tech start-up. DayTwo existing investors Seventure Partners and Johnson & Johnson were also participants at the event. DayTwo provides nutritional insights on intestinal bacteria and
The Intercontinental Exchange (ICE) Launches The NYSE Board Advisory Council
Reportedly, The Intercontinental Exchange (ICE) parent company of NYSE recently announced the launch of the NYSE Board Advisory Council to connect board candidates with NYSE-listed companies and conduct live networking sessions to promote diversity among corporate boards. The advisory council consists of 15 founding members,
Company News Around The Web
19 July 2019 | 9:00 pm
Edited Transcript of JNJ earnings conference call...
Q2 2019 Johnson & Johnson Earnings Call...
19 July 2019 | 3:06 pm
The Zacks Analyst Blog Highlights: Johnson &...
The Zacks Analyst Blog Highlights: Johnson & Johnson, Ne...
19 July 2019 | 2:23 pm
Intuitive Surgical's Q2 Performance Lauded By Bullish...
Canaccord Genuity analyst Jason Mills maintained a Buy rat...
19 July 2019 | 1:53 pm
Pharma Stock Roundup: JNJ & NVS' Q2...
J&J (JNJ) and Novartis (NVS) set the earnings season in ...
19 July 2019 | 12:56 pm
Dow 30 Stock Roundup: MSFT, JPM, IBM,...
The Dow endured a volatile week, primarily due to renewed tr...
18 July 2019 | 9:23 pm
3 Key Takeaways From J&J's (JNJ) Q2...
Here are some of the highlights of J&J's (JNJ) seco...
|Day Low - High||-|
|Year Low - High||-|